HOOKIPA Pharma (HOOK) Competitors

Werewolf Therapeutics (NASDAQ:HOWL) and HOOKIPA Pharma (NASDAQ:HOOK) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.

Which has higher valuation and earnings, HOWL or HOOK?

HOOKIPA Pharma has higher revenue and earnings than Werewolf Therapeutics. Werewolf Therapeutics is trading at a lower price-to-earnings ratio than HOOKIPA Pharma, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Werewolf Therapeutics	$1.88M	33.65	-$70.51M	-$1.67	-0.84
HOOKIPA Pharma	$43.95M	0.32	-$43.50M	-$5.85	-0.19

Does the media favor HOWL or HOOK?

In the previous week, HOOKIPA Pharma had 2 more articles in the media than Werewolf Therapeutics. MarketBeat recorded 3 mentions for HOOKIPA Pharma and 1 mentions for Werewolf Therapeutics. HOOKIPA Pharma's average media sentiment score of 0.25 beat Werewolf Therapeutics' score of 0.00 indicating that HOOKIPA Pharma is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Werewolf Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
HOOKIPA Pharma	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Is HOWL or HOOK more profitable?

Werewolf Therapeutics has a net margin of 0.00% compared to HOOKIPA Pharma's net margin of -785.66%. Werewolf Therapeutics' return on equity of -89.37% beat HOOKIPA Pharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Werewolf Therapeutics	N/A	-89.37%	-54.87%
HOOKIPA Pharma	-785.66%	-120.09%	-77.14%

Which has more risk & volatility, HOWL or HOOK?

Werewolf Therapeutics has a beta of 0.62, meaning that its stock price is 38% less volatile than the S&P 500. Comparatively, HOOKIPA Pharma has a beta of 0.89, meaning that its stock price is 11% less volatile than the S&P 500.

Do analysts recommend HOWL or HOOK?

Werewolf Therapeutics presently has a consensus target price of $8.33, suggesting a potential upside of 491.02%. HOOKIPA Pharma has a consensus target price of $4.50, suggesting a potential upside of 294.74%. Given Werewolf Therapeutics' stronger consensus rating and higher probable upside, research analysts clearly believe Werewolf Therapeutics is more favorable than HOOKIPA Pharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Werewolf Therapeutics	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
HOOKIPA Pharma	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Do institutionals and insiders hold more shares of HOWL or HOOK?

64.8% of Werewolf Therapeutics shares are owned by institutional investors. Comparatively, 63.9% of HOOKIPA Pharma shares are owned by institutional investors. 23.6% of Werewolf Therapeutics shares are owned by insiders. Comparatively, 3.3% of HOOKIPA Pharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Werewolf Therapeutics beats HOOKIPA Pharma on 10 of the 16 factors compared between the two stocks.